Polygenic hypercholesterolaemia: why do we want to know?
Prof Steve HUMPHRIES will be presenting at the HEART UK conference on Wednesday 7th July.
Polygenic hypercholesterolaemia: why do we want to know?
How knowing that a patient with clinical FH has a polygenic and not a monogenic cause for their phenotype is key in the clinician deciding on the appropriate patient care pathway
Find out more on our HEART UK conference pages. The Health Professional area of the website is intended only for healthcare professionals.
This event is intended for healthcare professionals from the UK and receives sponsorship from pharmaceutical companies
Related stories
- Saving the PASS system for the sake of England’s FH Services, for current and future generations
- The national Child Parent Screening Service (CPSS) pilot has been extended until October 2024
- Alternative cascade-testing protocols for identifying and managing patients with familial hypercholesterolaemia: systematic reviews, qualitative study and cost-effectiveness analysis
- how the NHS is working to deliver improved lipid management
- HEART UK 36th Annual Medical and Scientific Conference 2023 LIPIDS – THE BEST YET - CONFERENCE REVIEW
- Our new Lipidology Podcast
- Recently formed Lipoprotein(a) Taskforce publishes Call to Action to increase recognition and acceptance of Lp(a) as an ASCVD risk factor
- Lipoprotein (a) disorder gets SNOMED codes
- Would you like to update your knowledge of lipid management and have the opportunity to liaise with others working in this area?
- Familial Hypercholesterolaemia Gene Testing One-Day Online Workshop - Dates for 2023